Pharmaceutical companies have begun using social media for business needs and promotion, yet have been hesitant to become too engaged since the FDA’s stance on social media activity remained unclear.
Pharmaceutical companies have begun using social media for business needs and promotion, yet have been hesitant to become too engaged since the FDA’s stance on social media activity remained unclear. But now that we know the FDA’s specific guidelines for pharma companies’ actions online, it’s time for brands to consider diving into the social media pool.
What FDA Regulations Mean for You
But before we dive in too deep, here’s a refresher on what the FDA guidelines do:
How to Make the Most of Social Media (Within FDA Guidelines)
So, what does that mean for your company?
The FDA guidelines simply outline the proper use and behavior of pharma companies utilizing social media, just as there are guidelines for drug testing, marketing, and label warnings. With this new information, here’s what your company should do:
Making Pharma and Social Media Work Together
There are already great examples of pharma companies using social media in innovative ways. At last year’s European Respiratory Society Congress, Boehringer Ingelheim became the first pharmaceutical company to host a disease-focused Twitter hangout. Using #COPDChat to spawn conversations over four continents, the hangout made more than 1.7 million impressions and led to a 7-percent jump in the number of Twitter followers for the company.
Sanofi has fostered trust with its users by being forthright about its policies on monitoring user content on Internet properties. User comments are quarantined - delayed up to 24 hours before appearing publicly - so a Sanofi team member can provide additional information to clarify user questions or comments. Sanofi’s online community values its efforts to provide thorough and accurate information while maintaining transparency.
Device company Medtronic has made itself highly approachable to consumers by having a presence on Facebook, Twitter, LinkedIn, and YouTube, where users can ask questions directly of the company and receive enthusiastic responses and helpful information. That accessibility is part of the reason Medtronic now has more than 154,000 Facebook fans.
Just as social media changed the way our society communicates, it can change the way a pharma company interacts with consumers, promotes products or services, and is perceived by the public.
Establishing social media accounts for your brand will empower consumers to seek additional information, report issues, and provide feedback. At the same time, it allows you the opportunity to correct misinformation, soothe agitated customers, offer helpful resources, and display goodwill toward consumers. If your company uses these social media tips, you’ll be more engaged with and trusted by customers than ever before.
Ken Ribotsky is CEO of Brandkarma LLC. He can be reached at Kenneth.ribotsky@yahoo.com
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
2 Commerce Drive
Cranbury, NJ 08512